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Summary 
QUESTIONS UNDER STUDY: The starting point of the interdisciplinary project “Assessing 
the impact of diagnosis related groups (DRGs) on patient care and professional practice” 
(IDoC) was the lack of a systematic ethical assessment for the introduction of cost 
containment measures in healthcare. Our aim was to contribute to the methodological and 
empirical basis of such an assessment. 
METHODS: Five sub-groups conducted separate but related research within the fields of 
biomedical ethics, law, nursing sciences and health services, applying a number of 
complementary methodological approaches. The individual research projects were framed 
within an overall ethical matrix. Workshops and bilateral meetings were held to identify and 
elaborate joint research themes.  
RESULTS: Four common, ethically relevant themes emerged in the results of the studies 
across sub-groups: (1.) the quality and safety of patient care, (2.) the state of professional 
practice of physicians and nurses, (3.) changes in incentives structure, (4.) vulnerable groups 
and access to healthcare services. Furthermore, much-needed data for future comparative 
research has been collected and some early insights into the potential impact of DRGs are 
outlined.  
CONCLUSIONS: Based on the joint results we developed preliminary recommendations 
related to conceptual analysis, methodological refinement, monitoring and implementation. 
Key words: diagnosis related groups (DRG), cost containment, ethics, interdisciplinary 
research, healthcare reform, Switzerland 
Introduction 
Background to healthcare reforms, cost containment and DRGs 
Cost containment is a major concern for contemporary healthcare systems that aim to sustain 
affordable healthcare of good quality. Many countries are therefore in the process of 
restructuring healthcare towards more efficient and economically viable systems. One of the 
mechanisms to incentivise the efficient delivery of healthcare is the introduction of a payment 
system based on diagnosis-related groups (DRGs). DRGs were first introduced as a payment 
system for Medicare in the USA in 1983, and are being increasingly implemented worldwide 
[1]. If the DRG system is used as the basis for reimbursement – and not only for classifying 
cases –, payment is effected according to a prospectively calculated standard amount per case, 
rather than, for example, fee-for-service or per diem payment [2–4]. Swiss acute-care 
hospitals were required to implement a DRG-based prospective reimbursement system for in-
patient hospital care from 2012 on as part of a wider healthcare reform in Switzerland [5]1. In 
the literature, the advantages of introducing DRGs are described as an increase in the 
transparency of hospital services, an incentive for the efficient delivery of appropriate care, 
cost containment and the improvement of the quality of care [6–8].  
However, from the outset of DRG implementation, concerns have been raised about how 
DRGs might influence aspects of healthcare delivery such as the quality of patient care, 
access to care and professional practice. For example, DRGs could encourage hospitals to 
admit more cost-effective patients on average, while hindering access for patients who are 
likely to cost more than is typical for their diagnosis [2, 9, 10]. The potential negative impact 
of DRGs on the working environment and professional standards of healthcare practitioners, 
such as nurses and physicians, has also been considered: the financial incentives implicit in 
DRGs could contradict the ethical standards and responsibilities of nurses and physicians [11–
13]. Questions have also been raised about whether DRGs are achieving their often stated 
aims as some studies express doubts about whether DRG-based systems actually help to 
contain costs [6].  
From our point of view, successful healthcare reforms should not only be judged according to 
whether or not they contain costs but also according to any additional impact they might make 
on healthcare, be it at the level of population health, at the level of hospital management or at 
the level of individual healthcare settings. However, in most cases there is no comprehensive 
assessment of the impact of healthcare reforms on cost, quality and access to care, nor on the 
professional standards of healthcare practitioners. This is particularly striking given that there 
are well-elaborated international standards to evaluate risks, benefits and cost-effectiveness of 
pharmaceuticals, and that healthcare reforms arguably have an even larger impact on public 
health than pharmaceuticals do [14–16]. In addition, the implementation of DRGs particularly 
has not been considered according to a systematic ethical framework, neither in Switzerland 
nor elsewhere [17].  
In the wider context of changes in Swiss health policy, the DRG-based payment system and 
accompanying reforms have been implemented in a healthcare system with high patient 
satisfaction, which however, the OECD has described as having “a poor health information 
system”, and which requires better monitoring and reporting of quality of care in hospitals 
[18]. Despite these problems and even though in 2011 the OECD called for an improvement 
in cost containment in Switzerland, its health care system has been ranked as one of the best 
worldwide [19]. Due to its superior performance, the Swiss healthcare system has been 
considered as a possible model for other countries [20, 21]. If Switzerland succeeds in 
systematically assessing the impact of the introduction of DRGs, this assessment could also 
provide a model for evaluating cost containment reforms in other countries.  
The IDoC project 
The starting point of our interdisciplinary IDoC project, “Assessing the impact of diagnosis 
related groups (DRGs) on patient care and professional practice”2, was the lack of a 
systematic assessment of the introduction of cost containment measures in healthcare in 
general. Our aim was to provide a pioneering model for such an assessment, and we chose to 
study the example of DRGs, as they were about to be introduced in Switzerland. Our research 
consisted of (1.) providing a systematic ethical framework for our research, (2.) developing 
elements of tools for future use in monitoring the impact of DRGs, and (3.) performing 
empirical research on the impact of DRGs from various perspectives. Since significant ethical 
values underlie cost containment, quality of and access to care, and professional practice, the 
overall context for the project was set by the discipline of biomedical ethics. However, we 
explicitly aimed to benefit from the resulting synergies of the different disciplines involved 
(medical ethics, law, nursing science and health services research) [4, 22]. Such a far-reaching 
reform of the healthcare system, as it took place in Switzerland, is bound to have multiple 
effects. By adopting an interdisciplinary approach we aimed to avoid jumping to conclusions 
based on results in one area only. Instead, our project was developed in order to consider a 
wider array of parameters than standard approaches and to place these results within an 
ethical context.  
To develop such a multidisciplinary project, and to perform empirical research on isolated 
elements of complex changes in healthcare – the introduction of DRGs was only one of 
several aspects of the healthcare reform in Switzerland – is challenging on many levels [4]. 
One of the principal challenges is to deal with the difficulty of causal attributions between 
changes in healthcare and the introduction of particular measures, such as DRGs, especially in 
such a short period of study – only three years3. Even though we provide some empirical data 
on the years 2011–2013 our primary aim for the IDoC study was therefore not to provide a 
comprehensive empirical assessment of the effects of DRGs, as this would have required a 
longitudinal study over a longer time span. However, these limits in terms of empirical 
results, and which are prevalent in much of the literature, are precisely part of the reason why 
we have developed a framework for understanding how specific and isolated results should be 
understood within a wider research, policy and ethical context.  
While individual papers have been published by the subgroups during the course of the study, 
this paper intends to provide an overview of the results and recommendations of the IDoC 
project as a whole.  
The five sub-projects included the disciplines of Biomedical Ethics (Project Leaders (PL): 
Nikola Biller-Andorno and Verina Wild, University of Zurich), Law (PL: Bernice Elger, 
University of Basel, and Thomas Gächter, University of Zurich), Nursing Sciences (PL: 
Rebecca Spirig, University Hospital Zurich), Health Services Research I (PL: Dragana 
Radovanovic, University of Zurich), and Health Services Research II (PL: Bernard Burnand 
and John-Paul Vader, University of Lausanne).  
Table 1: Matrix for identifying the ethical implications of the implementation of DRGs. 
Reprinted from Fourie C, Biller-Andorno N, Wild V. Systematically evaluating the impact of 
diagnosis-related groups (DRGs) on health care delivery: a matrix of ethical implications. 
Health Policy. 2014;115(2-3):157-64, with permission from Elsevier. 
1. Value/s 2. DRG-specific factors 
3. Examples
Macro-level Meso-level Micro-level 
  
Effects of DRGs 
on primary 
ethically relevant 
parameters: 
  
i. Utility Cost & efficiency
(D) Do DRGs 
help to contain 
costs for the 
healthcare 
system? 
(D) Is efficiency 
under DRGs 
correlated with 
the kind of 
hospital providing 
the service? 
(M) What, if 
anything, can we 
learn about the 
impact of DRGs 
from HCPs’ 
perceptions of 
efficiency? 
ii. Producing 
benefits Quality of care 
(N, M) How 
should we define 
and measure good 
quality of 
healthcare? 
(D) How is 
patient safety 
affected by the 
implementation 
of DRGs at 
specific 
hospitals? 
(D) How, if at all, 
do DRGs 
influence the 
quality of care for 
individual 
patients? 
iii. Distributive 
justice 
Access to 
healthcare 
(N) Is sufficient 
access to health 
care a 
fundamental 
requirement of 
justice? 
(D) Does the 
implementation 
of DRGs affect 
access to care at 
specific 
hospitals?  
(D) What are 
HCPs’ 
perceptions of 
how vulnerable 
groups are 
affected by 
DRGs? 
iv. Transparency Hospital transparency 
(D) Do DRGs 
result in greater 
pricing 
transparency? 
(D) Are the 
procedures in 
place at specific 
hospitals 
conducive to 
promoting 
transparency? 
(M) How, if at all, 
can hospital 
transparency be 
judged at a micro-
level? 
v. Autonomy Patient autonomy
(N, M) What is 
patient autonomy 
and how should it 
be measured? 
(D) Do DRGs 
lead to greater 
competition 
between specific 
hospitals and does 
this impact on 
patient choice?  
(D) How, if at all, 
does the 
implementation 
of DRGs affect 
the autonomy of 
individual 
patients, e.g. 
through an impact 
on informed 
consent? 
  
Effects of DRGs 
on secondary 
ethically relevant 
parameters: 
  
vi. 
Professionalism 
(and links to 
above values)  
Adherence to 
ethical standards 
(N) Which ethical 
obligations 
should be 
contained in 
HCPs’ 
professional 
standards? 
(D) Have 
hospitals adapted 
their policies on 
professionalism 
in response to the 
implementation 
of DRGs? 
(D, N) Does cost 
containment 
cause conflict 
with the 
professional 
standards of 
HCPs? 
vii. (Potential 
links to above 
values) 
Work 
environment& job 
satisfaction 
(N, M) What 
impact, if any, 
does HCPs’ job 
satisfaction have 
on the primary 
parameters? 
(D) Which 
procedures, if 
any, do hospitals 
have in place for 
counter-acting 
any effects that 
DRGs could have 
on workload? 
(D) How do 
DRGs influence 
HCPs’ 
perceptions of 
workload and job 
satisfaction? 
  
Ethics of DRG-
related decision-
making 
procedures: 
  
viii. Procedural 
justice 
The fairness of 
the procedures of 
health care reform
(D, N) Did the 
processes leading 
to DRG-based 
health care reform 
comply with 
‘public 
accountability’? 
[Not applicable at 
a meso-level] 
[Not applicable at 
a micro-level] 
D = descriptive; M = methodological; N = normative; HCP = healthcare practitioner 
Note: The questions in the individual cells are of exemplary character, and do not represent 
the spectrum of questions that could be asked. 
Methods  
Framing the project systematically: an ethical matrix for identifying the ethical implications 
of DRG-based systems  
Our literature reviews for the overall IDoC project indicated that no attempt had been made to 
systematically assess the major ethical issues associated with DRGs or other cost containment 
measures. In order to ultimately develop tools to assess the potentially significant impact of 
cost containment measures in healthcare on a number of ethically relevant issues, one of our 
central joint results of the IDoC project was the development of an ethical matrix that frames 
the IDoC project [17]. As we have chosen the example of DRGs in Switzerland as our 
primary research focus, the matrix was generated by reviewing the literature on DRGs and 
collecting empirical data, and by analysing and assessing literature on ethical frameworks in 
public health and clinical ethics. The matrix helps us to situate our own research questions in 
a framework at various levels of the health care system in order to understand how our 
research can contribute to determining the impact that DRGs have on ethically relevant 
factors (table 1). The matrix has been explicitly formulated in such a way that it could be 
adapted for assessing other cost containment measures in other contexts. 
Individual study designs 
The focus of this paper is to present the first joint results and the overall recommendations of 
the IDoC project. However, in order to understand the joint results better, the aims and 
methodologies associated with each sub-project can be briefly described as follows:  
Sub-project A: DRGs and changes in healthcare: an analysis of the ethical issues and their 
perception by physicians (Area: Medical Ethics) 
The aim of Sub-project A was to determine which ethical concerns physicians perceived or 
expected, and in which way they attributed these changes to DRGs. Examples of these 
concerns are conflicts of interest, perceived limitations to professional autonomy, observed 
discrepancies between physicians’ ethical standards and real life practice, and expected 
implications for work motivation and job satisfaction. We conducted two quantitative studies 
among physicians working in Swiss hospitals for acute care [23]. The first consisted of an 
online questionnaire at the end of 2011 (n = 776); the second was a paper-and-pencil 
questionnaire in the summer of 2013 (n = 382). The benefit of the surveys was twofold: 
firstly, we wanted to generate empirical data on the status quo. As the second study was 
performed after the introduction of DRGs, an early pre-post comparison was possible, but was 
not our primary aim. Due to the short time span we did not expect major changes, but wanted 
to lay the basis for future follow-up studies. Secondly, and more importantly, the design of the 
questionnaires and the method of distribution were intended to help develop a survey tool for 
monitoring the impact of DRGs (or other cost containment measures) on professional practice 
in the future.  
Sub-project B: DRGs in Switzerland: critical analysis of the legal aspects and their perception 
by experts and hospital managers (Area: Law & Ethics) 
Sub-project B aimed to (1.) analyse the legal changes associated with DRGs and (2.) to 
evaluate whether and how the changes associated with the Swiss-wide implementation of 
DRGs affected the attitude of hospital managers and experts in hospitals. In the first part, the 
following legal questions relevant to the introduction of DRGs were examined according to 
the themes of rationing and discrimination. Do DRGs create a form of more or less visible 
rationing? How much control do experts have for ensuring just and equal access to 
healthcare? The second, empirical part aimed at studying the impact of the new legal 
instruments (duty to admit all patients, acute and transitional care) on hospital decision 
making, especially with respect to the risk of discrimination and rationing, and at describing 
and analysing expectations and fears. The sample consisted of hospital directors and persons 
responsible for quality, coding, finance, and medicine controlling (n = 43). The qualitative 
interviews were conducted in 2012 in 24 cantons of Switzerland, resulting in 11 interviews in 
French- and Italian-speaking Switzerland and 32 interviews in German-speaking Switzerland 
[24–27]. Qualitative content analysis was used for the interpretation of the text material 
(1,708 quotations, 531 pages, 215,547 words) and was carried out according to Mayring [28, 
29]. 
Sub-project C: Monitoring the impact of the DRG payment system on the nursing service 
context factors in Swiss hospitals (Area: Nursing Sciences) 
Sub-project C examined nursing service context factors, such as the complexity of nursing 
care or leadership, which influence nursing-sensitive patient outcomes. First, empirical data 
on the status quo was gathered and second a conceptual model and tool for the future 
monitoring of DRGs was further developed. The study was a cross-sectional survey and not 
designed as a pre-post comparison; we are aiming for a longitudinal analysis through future 
comparative studies. 
The study – a mixed methods design in the form of a sequential explanatory strategy – was 
conducted at three University Hospitals and two Cantonal Hospitals prior to DRG-
introduction [44]. With a set of questionnaires we evaluated the quality of the work 
environment, leadership, moral distress, job satisfaction, and nursing performance [30–35, 
45]. Our sample consisted of 5156 Registered Nurses (RNs) and clinical nurse specialists, as 
well as the unit managers from 204 inpatient units. Additional personnel and patient-related 
data such as grade mix, nurse turnover, workload, complexity of nursing care, average length 
of stay and nursing-sensitive patient outcomes were obtained from other electronic sources of 
information. The results were analysed by means of descriptive and inferential statistics. 
Additionally, we conducted 32 focus group interviews in 2012. The sample consisted of 224 
RNs, clinical nurse practitioners involved in direct patient care and unit managers of the five 
hospitals. The data of the focus group interviews was analysed through knowledge maps and 
content analysis according to Mayring [28].  
The outcome of our study is an improved monitoring model based on the results of this first 
cross-sectional survey as well as the further development of a set of instruments and 
performance metrics. Nurse leaders and professional development initiatives will benefit from 
the data generated, providing a basis for discussions and for measures taken to ensure quality 
of care and to support practice development. 
Sub-project D: The impact of the implementation of the DRG system in Switzerland on 
evidence-based treatment of patients with acute myocardial infarction (Area: Health Services 
Research I) 
The aim of the sub-project was to assess the quality of evidence-based treatment for acute 
myocardial infarction (AMI) patients one year before and one year after the introduction of 
the Swiss DRG system. For this purpose we designed a measurement set using clinical data 
independent from administrative coded data that are linked to the coding guidelines and 
regulations of the DRGs themselves [36]. All hospitals participating in the AMIS Plus4 
registry in both years 2011 and 2012 were selected, and patients presenting with an AMI 
diagnosis within the first 24 hours of symptoms onset were included.  
We measured ten items from the patient’s symptom onset until hospital discharge as 
indicators for adherence to treatment guidelines. Secondary endpoints were the in-hospital 
outcomes (mortality, complications, length of hospital stay) and access to healthcare for 
clinically vulnerable populations defined before the start of the study. Vulnerable patient 
groups were defined based on literature and available records in the AMIS Plus registry, and 
included patients with advanced age, female gender, co-morbidities, or AMI related cardiac 
insufficiency at admission defined with Killip classes 3 or 4 [37–40]. 
“SAMI-Q” (Swiss Acute Myocardial Infarction and Quality), the resulting tool from our 
subproject combines three types of measurements: the quality of the delivered treatment; the 
quality in terms of in-hospital outcomes with the measurement of the mortality rate, the 
percentage of major adverse cardiac and cardiovascular events, and the length of hospital stay 
in days; access to care and in-hospital outcomes of clinically vulnerable patients.  
Sub-project E: Developing and refining indicators to measure the impact on patient safety of 
generalised use of DRGs for hospital reimbursement in Switzerland (Area: Health Services 
Research II) 
The aim of sub-project E was to evaluate potential changes in patient safety related to the 
introduction of DRGs by means of patient safety indicators (PSI) based on routinely collected 
data. Intermediate objectives were to: (1.) assess the accuracy of a subset of PSI algorithms in 
one university hospital, using the information collected in medical charts; (2.) assess the 
accuracy of some PSIs against other reference standards (e.g. existing indicators); (3.) 
document and investigate the frequency, variations and potential biases of PSI, using hospital 
discharge data collected by the Swiss Federal Statistical Office (Hospitals Medical Statistics); 
(4.) evaluate trends in PSI for Swiss hospitals for the years 2008–2014.  
The seven PSI selected for this study were: decubitus ulcer, bloodstream infection related to 
vascular catheter, postoperative physiological and metabolic disorders, post-operative deep 
vein thrombosis and pulmonary embolism (VTE – venous thrombo-embolism), post-operative 
sepsis, and obstetric trauma during vaginal delivery with/without instrument.  
The seven ICD-10 PSI were based on a framework algorithm (table 2). 
These individual algorithms for the different PSIs can be used to follow the evolution of the 
impact of the use of DRGs, but also any system-wide changes with the potential to affect 
patient safety. 
  
In summary, the IDoC project examined the perspective of healthcare professionals (Sub-
projects A and C), the perspective of hospital managers and administrative personnel (Sub-
project B), the impact on the adherence to clinical guidelines (Sub-project D), and the impact 
on Patient Safety Indicators (Sub-project E).  
Table 2: Framework algorithm as base for the seven ICD-10 PSIs.  
PSI = (secondary diagnosis codes corresponding to the clinical definition of the selected PSI) 
/ (population at risk defined by DRG codes, principal diagnosis codes, secondary diagnosis 
codes, procedure codes) 
Joint results 
The IDoC project intended to reach an advanced level of data interpretation that would go 
beyond what each group was capable of individually. As stated above, an explicit aim was to 
benefit from the resulting synergies of different disciplines. A continuous exchange between 
the groups was therefore necessary. The joint results and recommendations were developed 
during six workshops [41], various telephone conferences, and bilateral meetings held by the 
IDoC group.  
First, we can claim our systematic matrix (see table 1) as one of our major joint results. We 
started developing this matrix from the beginning of the project as a methodological and 
ethical frame for our research. However, it is also a joint result in the sense that is has evolved 
over the course of the project, profiting from the group discussions.  
Secondly, we are in the process of developing a more comprehensive “package” of tools for 
future use in the quality management of hospitals. The quantitative and qualitative studies 
developed by each group in fact represent elements of these tools. More collaborative work is, 
however, necessary to bring these methods together and to provide valid and effective tools 
that can be used outside the research context.  
Third, central themes have emerged, which affected every discipline involved to different 
degrees and which were discussed by the IDoC group. These areas include (I) the quality and 
safety of patient care, (II) the state of professional practice for nurses and physicians, (III) 
changes in incentives structure, (IV) vulnerable groups and access to healthcare services. This 
list is not meant to present a structured or comprehensive list; instead, it indicates the 
recurring and ethically significant topics which were not confined to one or two disciplines. 
We discuss these topics in greater detail below.  
Emerging central themes 
The quality and safety of patient care in general 
A general answer as to whether quality of care has changed after the introduction of DRGs is, 
at this stage, not possible. Even in the future it may not be possible to answer this question on 
a general level for several reasons:  
First, at this stage our study cannot detect any major changes in quality of care as DRGs have 
only recently been introduced Swiss-wide. Long-term effects on quality of care can only be 
identified if the monitoring of quality of care continues over the next years and decades. It 
will therefore be of crucial importance to continue the monitoring of quality of care.  
Secondly, a general assessment of quality of care will fail to provide differentiated answers. 
A crucial result of our study is that quality of care needs a nuanced definition and 
understanding. Only once we have such an understanding can different aspects of quality of 
care be evaluated. On the one hand, such a differentiated assessment would need to look at 
“hard data”, such as measurable clinical indicators like patient mortality or infection rates. On 
the other hand, soft or indirectly related factors such as quality of nursing care, time for 
patient-physician interaction, teamwork, and the education of healthcare professionals also 
need to be taken into account for a more differentiated assessment of quality of patient care.  
A third issue is the difficulty of causal attribution of changes in quality to a specific 
intervention such as the introduction of DRG-based reimbursement. If changes do occur in the 
quality of care, it is very difficult to determine whether a particular intervention is responsible 
for that change. For this reason, we consider the perceptions of healthcare professionals, who 
have first-hand experience with DRGs as well as with other reimbursement systems, to be of 
particular importance as they may point to causal relationships that merit further scrutiny. 
However, the perceptions could also be related to other changes in healthcare such as 
increasing competition between hospitals or increasing transparency, and not explicitly to 
DRGs. Future quality assessments that try to link certain changes in quality to certain 
reimbursement systems will have to deal with the problem of causal attributions.  
Specific answers to determining the quality and safety of patient care  
For a more nuanced understanding of quality and safety of patient care it could be promising 
to try to identify “hot spots”, i.e. specific ethically problematic areas related to the increased 
emphasis on cost containment and to try to monitor and assess these in relation to quality of 
care. According to our experiences within the IDoC project, “hot spots” include for example: 
insufficient quality management (A), the existence of over- and under-treatment as a result of 
the incentives inherent in DRGs (A), less time for communication with patients, relatives and 
within the care team (A), more time for administration (A), limitations to realising important 
professional principles in daily practice that may influence quality of medical care (A), the 
existence of case splitting (A), a decrease in “patient-oriented care” (A), the delay or 
cancellation of necessary patient care provided by nurses (C), worse in-hospital outcomes for 
some “vulnerable patient groups” (D), inadequate collaboration with home care, long-term 
inpatient care and rehabilitation clinics (B), omission of treatment for which success is 
estimated to be low (B), and the problem of cost reduction, for example in laboratories, 
without risking patient safety (B). It will be important to identify further “hot spots”, but also 
to monitor and assess the intended positive changes of DRGs, such as the following in order 
to reach a balanced evaluation of changes in healthcare.  
Possible improvements related to the introduction of DRGs were for example: earlier 
discharge without a reduction of adherence to clinical guidelines or worse outcome (D, B), 
quality leap due to more accurate processes (B), an increase in process quality and patient 
safety due to standardised patient pathways (B), better functioning of hospital information 
systems with the possibility to access important data quickly and safely (B), improved 
possibilities for working towards structural reforms as it is easier to see where medical 
priorities need to be set and where hospitals should invest (B), and a concentration on certain 
areas of clinical expertise which helps to reduce costs and at the same time to reach a critical 
mass per intervention allowing good quality (B). 
In the attempt to capture quality in a more nuanced way, IDoC also encountered various 
methodological challenges e.g. in relation to the collection of data or the permission to access 
certain databases or study groups. Future assessments will have to deal with such constraints. 
As an example we had to work with a (previously known) delay in accessing the official 
source data from the Federal Office of Statistics (more than 2 years after the index year) (E), 
the lack of possibility to follow hospitals from year to year, because the data is anonymised 
and the anonymised identity is changed from year to year (E), and a lack of resources for 
validating PSI using a chart review of medical records, including the cost for collecting data, 
and for obtaining appropriate sampling from various hospitals (E).  
The state of professional practice for nurses and physicians 
Our research indicates that in Switzerland job satisfaction among nurses and physicians is 
high. However, the participants report a number of problems related to the adherence to 
professional ethos and to their working conditions. Whether and how they are related to 
DRGs is difficult to assess, given the complexity of the healthcare reform in Switzerland. At 
this point we can only rely on the subjective attribution of these experiences to the 
introduction of DRGs. 
The problems detected by the IDoC project include: the deterioration of the work satisfaction 
of physicians attributed to SwissDRG (A), difficulty for physicians to implement professional 
principles – such as focusing on the wellbeing of the patient, respecting patient preferences, 
and having sufficient time for patients – under current working conditions (A), less time for 
their own training and continuing education and that of young colleagues since the new 
hospital reform (A), an increase in the multi-morbidity of patients and a growing complexity 
of care that needs to be met by adequate nursing staff (C), experience of moral distress among 
nurses (C), and the intention of some physicians and nurses to leave their jobs or reduce work 
hours (A, C).  
Changes in incentives structure 
Another recurring topic in our joint discussions was the ways in which cost containment 
instruments can incentivise behaviour. Before the introduction of DRGs in Switzerland many 
hospitals were reimbursed according to day rates. At that time physicians were incentivised to 
keep patients longer than necessary. According to the interviews with hospital managers and 
legal experts (B), the implementation of SwissDRG has changed the incentive structures in 
various ways, namely with respect to a decreased length of stay, more efficient use of 
resources and higher productivity, general cost awareness, improvement of the quality of 
treatments, structures, processes, and increased transparency. 
However, we also found examples of ways in which DRGs may be incentivising behaviour 
that raises concerns: case splitting, unnecessary care, rationing of medical services, 
unnecessary hospital admissions if outpatient care is also possible, and keeping patients in 
hospital longer than necessary because the minimum length of stay was not reached (A) as 
well as a reduction of medical training activities and misdirected incentives resulting in 
disadvantages for vulnerable groups [24].  
In the area of nursing, we found that DRGs can incentivise the reduction of nursing 
interventions when they are in competition with interventions required immediately by the 
patient or with interventions ordered by physicians (C). Focus group interviews showed how 
the failure to carry out nursing interventions can have consequences for patients and for 
nurses (C). It was reported that adverse events such as patient falls or pressure ulcers occur 
more often in these situations. In addition, recovery time is lengthened and it can take longer 
for patients to reach the desired level of self-care and self-management. Our studies have 
shown that this inadequate setting of priorities can lead to nurses experiencing feelings of 
guilt, moral distress, dissatisfaction, frustration, and even anxiety [35].  
Even though we detected problems with the incentives inherent in DRGs, we believe that 
most, if not any, alternative hospital reimbursement system brings with it incentives. The 
challenge is to monitor the effects of any incentive system and to compare them to alternative 
strategies for containing costs in healthcare.  
Vulnerable groups and access to healthcare services 
Another recurring topic was the “vulnerability” of patient groups. Firstly, we found it difficult 
to define vulnerability in the context of DRGs and secondly, it was a methodological 
challenge to prove that vulnerable groups have been affected. In the literature there has been a 
large amount of speculation in terms of which groups might be vulnerable under a DRG-
based system. Although very little empirical data is available up till now, we can cautiously 
draw some general results regarding DRG-related vulnerability in Switzerland.  
Fair and appropriate access to healthcare is required by Swiss law. Ensuring access is 
primarily an issue of social, fiscal, or health policy that should be defined by policy makers. 
“Vulnerable groups” within the Swiss DRG system can be defined in two ways. There are 
pre-defined groups, mostly based on social characteristics, such as migrants, poor patients and 
patients without family or other social networks, who are at risk of suffering disadvantages in 
the DRG system. A second definition is also required in order not to miss certain vulnerable 
persons who do not fit such predefined categories. As part of that definition, groups that are 
vulnerable in the DRG system are defined post hoc, which means patients for whom 
refunding is not properly represented within the tariff structure which has been agreed upon 
with the Swiss cantons. However, according to hospital experts, this problem is mostly passed 
on to the individual healthcare service providers, and no solution has been provided at the 
more general cantonal level (B). Hospitals are currently trying to negotiate the refunding of 
these groups. If the cantons accept the “vulnerability” of these groups and the importance of 
refunding them, additional support can be negotiated between hospitals and cantons. This 
could help to at least partially address discrimination in care for vulnerable groups. Efforts of 
hospitals to obtain certifications like, for example, “migrant friendly hospital”, can contribute 
to strengthening the awareness to keep entrance thresholds low. Especially public hospitals 
stress their mandate to guarantee access to healthcare services to all patients groups at all 
times and avoid selective treatments [25].  
Discussion 
The IDoC project aimed to identify systematically the ethically relevant issues related to the 
implementation of DRGs. As a project funded as part of the Sinergia programme of the Swiss 
National Science Foundation, IDoC has been working on two levels over the course of three 
years of research. On the individual level, sub-projects have conducted independent research, 
and specific results have been provided in each of the different disciplines. Additionally, 
IDoC has functioned synergistically, identifying recurring themes, discussed in the previous 
section. Given that DRGs affect the macro-, meso- and micro-level of the healthcare system 
and are perceived differently from various perspectives, such a collaborative effort was the 
appropriate strategy for addressing the research topic.  
Our project can serve as a preliminary model for future more comprehensive and systematic 
research on the effects of DRGs or other provider payment systems. The ethical matrix is 
particularly significant in terms of being able to structure research within an ethical context. 
While the matrix was developed in light of the Swiss healthcare reform, it can also be used as 
a basis for identifying the ethical implications of DRG-based systems in other countries and 
for highlighting the ethical implications of other kinds of payment provider systems. As 
healthcare reforms and the introduction of cost containment instruments are usually not 
systematically assessed from an ethical point of view and there is a lack of guidance in the 
literature, our project can be seen as one of the first attempts to model such an assessment. 
The success of the assessment depends on various factors, such as starting to plan early 
enough in order to gather before-and-after-data adequately and to build up functioning 
interdisciplinary networks further, as well as being aware of and meeting the array of 
methodological problems that come with such a complex project. So far, IDoC has only been 
able to work with pre- or early-implementation data. More analyses will be needed as post-
implementation data become available. 
Some important limitations of our project should be mentioned. The first one is the lack of 
more relevant empirical information on healthcare quality and access in Switzerland long 
before the introduction of DRGs. There is insufficient data, for example, on access, vulnerable 
groups, disease management, ethos of healthcare professionals, in order to make precise pre-
post comparisons. For example, our surveys of nurses and physicians aimed primarily at 
providing data on the status quo and cannot be compared to data in the past (as it does not 
exist) but at least could and should be compared to future data in order to measure and 
monitor nurses and physicians’ perceptions of professional practice on a long-term basis.  
Secondly, any changes found before and after 2012 cannot be solely attributed to the 
introduction of DRGs. A number of adaptations occurred along with SwissDRG, among them 
a new regulation of cost-sharing between cantons and insurers, the creation of a single 
hospital market with free choice of hospital, the guarantee of entrepreneurial freedom and the 
safe-guarding of quality (Botschaft betreffend die Änderung des Bundesgesetzes über die 
Krankenversicherung: BBl 2004 5551, 5564). It will remain difficult, if not impossible to 
settle on clear causal relations between the introduction of isolated measures in healthcare 
reform (such as DRGs) and surveyed changes, but it will be possible to ask professionals 
whether they attribute changes to a certain measure. This can serve at least as a signpost for 
potentially problematic areas.  
A final limitation is the lack of additional perspectives, for example, those of patients. It 
would have been an asset to the international literature and to our project specifically to 
survey patients’ experiences before and after the implementation of DRGs, and this 
perspective should be included in future studies. It will also be of interest to link results with 
economic issues in the future, for instance to cost shifting between inpatient and rehabilitative 
care.  
Conclusion 
In this paper we have given an overview of the IDoC project in Switzerland. We have 
described the advantages and limitations of our pioneering attempt to systematically assess 
and monitor ethically relevant changes in healthcare after the introduction of DRGs in 
Switzerland. As has become clear, this endeavour is a complex process and only in its 
beginning stages, not only in Switzerland, but worldwide. More concrete guidance on the 
situation in Switzerland can be given only once possible pre-post changes can be more fully 
captured a few years into the implementation of DRGs. Still, it has already become apparent 
that there are various future activities needed in the field, which we briefly sketch as a 
conclusion: 
Conceptual analysis: From our point of view, some concepts related to DRGs deserve closer 
analysis. For example, effects on the “quality of patient care” are frequently discussed in 
health economics, healthcare system research, and ethics. However, it is not clear, what 
exactly falls under “quality of patient care”. As we have explained, effects can range from 
very obvious ones, e.g. on patient mortality, to much more subtle effects for example on the 
quality of interaction between healthcare professionals and patients. To capture these effects, 
a nuanced, comprehensive understanding of quality is necessary.  
Methodological refinement: So far the methods for comprehensively assessing the impact of 
DRGs are not sufficient in any country. In the IDoC project we have made an effort to jointly 
develop methodological tools that capture more fine-grained aspects of the quality of 
healthcare. These tools were piloted during our studies and can, once they have been further 
refined and validated, enrich the instruments already available for assessing the quality of 
care. However, further joint efforts, also on an international level, are necessary to enhance 
such methods. It is crucial to plan an assessment of changes in healthcare according to a long-
term perspective, in order to capture positive and negative effects well enough. We expect 
various methodological challenges for such a long-term assessment, such as the problem of 
causal attribution, and difficulties in accessing databases or study populations. Future projects 
will have to find appropriate ways to deal with such challenges. 
Monitoring: Conflicts of interests caused by economic or other non-care related 
considerations can affect the quality and equity of patient care through, for example, medical 
errors and other patient safety problems. However, current monitoring still focuses on a very 
narrow set of indicators. This spectrum should be broadened to include the full set of issues 
that may arise from incentives introduced by DRGs (or other reimbursement systems). In 
doing so, the different dimensions of healthcare quality – e.g. safety, effectiveness, timeliness, 
and efficiency as well as personalised and equitable care [42] – should be taken into 
consideration. 
Implementation: We need an increased effort to bridge the gap between research on the one 
hand and management and policy decisions on the other. Empirical data can provide 
important feedback on governance in individual healthcare institutions as well as at the level 
of national health systems. However, translating the results of academic studies into 
information useful for management or policy processes requires a targeted effort. This 
becomes ever more prominent as health systems are increasingly conceived as being “learning 
systems”, that is, systems that constantly improve according to evidence and that effectively 
aim at the best value for the patient [43].  
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Footnotes 
1 Some hospitals in Switzerland were already operating under a DRG system before 2012 
although January 2012 was the first time that the new tariff structure ‘SwissDRG’ – 
developed from the German G-DRG – was made mandatory for all acute-care Swiss 
hospitals. 
2 The IDoC project has been funded by the Swiss National Science Foundation over the 
course of three years from 2011–2013. 
3 See also: Chapters “Emerging central themes” and “Discussion”. 
4 AMIS plus registry is an ongoing observational clinical study, registered at 
ClinicalTrials.gov (identifier NCT01305785), approved by the Supra-Regional Ethics 
Committee for Clinical Studies, the Swiss Board for Data Security, and the Cantonal Ethics 
Commissions. 
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